High Enroll
PrivateLast Round
Seed
Nov 15, 2022
Total Funding Raised
$2.63M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
High Enroll is a biotechnology company that provides a digital platform to streamline clinical trial participant recruitment for healthcare providers and research institutions.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Vertical SaaS
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
High Enroll Comparables
Compare High Enroll with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EnrollNow | 83% | |
| Trially AI | 78% | |
| uMotif | 77% | |
High Enroll Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 15, 2022 | ||||
| Seed | Aug 4, 2022 | ||||
| Pre Seed | Jul 16, 2020 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 179% MoM, from 348 to 970.
- Jan 21, 2025
Monthly visitors increased 43% MoM.
High Enroll Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about High Enroll's valuation, stock price, and market status.